The complex actions of serotonin (5-HT) on blood vessels is attributed to interactions with a multiplicity of specific 5-HT receptors located in smooth muscle and endothelium, sometimes mediating opposite effects.
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In the case of rat aorta, at least the 5-HT 2A receptor is functionally present 1) and it mediates potent vasoconstriction with a relatively low affinity for 5-HT. Apart from this receptor, 5-HT 2B , 5-HT 1B , and 5-HT 7 mRNAs have been detected in this tissue 2) by polymerase chain reaction (PCR) techniques. The corresponding receptors mediate different responses in the isolated preparations where they have been functionally described: the 5-HT 2B receptor has been located in the endothelium of pig pulmonary artery 3, 4) and rat jugular vein, 5) mediating relaxation. It has also been proposed that this receptor in smooth muscle mediates vasoconstriction in the mesenteric artery of mineralocorticoid hypertensive rats. 6, 7) The 5-HT 1B receptor has been described in a variety of tissues (for example, human coronary arteries, 8) rabbit epicardial coronary arteries, 9) human temporal artery, 10) human and bovine cerebral arteries 11) ) and mediates vasoconstriction when located in smooth muscle or relaxation when in endothelium. The 5-HT 7 receptor is located in smooth muscle, where it induces vasorelaxation (for a review see 12) ) in many preparations such as canine coronary and cerebral arteries, 13, 14) dog basilar artery and cerebral blood vessels, 15, 16) and cynomolgus monkey isolated jugular vein. 17) In addition, functional effects of some of these receptors appear to be related to the preconstriction of the tissue. Thus contractile synergism between 5-HT and other vasoconstrictor substances has been observed in peripheral and cerebrovascular blood vessels (for a review see 18, 19) ). For example, in guinea pig isolated iliac arteries 5-HT 1 -like silent receptor appears only in the presence of vascular tone. 20) The same phenomenon has been described in bovine isolated pulmonary arteries 21) and in rabbit isolated mesenteric arteries, 22) where preconstriction of the tissue with different contractile agents revealed potent vasoconstrictory effects of 5-HT. In rat aorta, a mutual amplification in contractile responses by simultaneous activation of a 1 and 5-HT 2 receptors has been described. 23) This phenomenon may play an important role in certain pathological states such as hypertension, peripheral vascular disease, and coronary spasm.
18) The importance of preconstriction is even greater in the case of relaxant receptors because normally preconstriction is needed for a relaxant response to occur.
Taking all these data together, the effects of 5-HT on blood vessels are complex and dependent on the anatomical location of the receptors and on additional factors such as preconstriction of the tissue with a non-5-HT receptor agonist that could unmask previously inactive or "silent" 5-HT receptor subtypes. In the preparation we have studied, rat aorta, the presence of mRNA for different 5-HT receptors (5-HT 2B , 5-HT 1B , 5-HT 7 ) with opposite actions, relaxation or contraction, is described. These effects can overlap in their functional response to 5-HT.
The aim of this study was to characterize the possible functional role of the receptors previously described in the literature using PCR techniques, 2) and to study the already known 5-HT 2A receptor-mediated response more thoroughly by investigating the influences endothelium and preconstriction may have on the potency of 5-HT in the 5-HT 2A receptor.
MATERIALS AND METHODS
Preparations Male Sprague-Dawley rats (250-300 g in weight) were killed by decapitation after being anaesthetized with CO 2 . The descending aorta was carefully removed, cleaned, and cut into 3 or 4 rings 4 mm in length which were then mounted in organ baths containing 20 When required, the endothelium was removed mechanically by rotating the vessel along a cotton bud. All the tissues were allowed to stabilize for 60 min under 2 g of resting tension, with washing every 15 min. Then, the presence of endothelium was confirmed by adding 1 mM acetylcholine after contraction with 0.1 mM phenylephrine (PE). A preparation was considered to have endothelium when the relaxation evoked by acetylcholine was at least 70%. After cumulative concentration-response curves (CCRCs, see below) had been determined, the rings were washed twice every 15 min, to remove all possible bound drug. Data were recorded using a Grass FTO3C isometric transducer and a Grass 7D polygraph.
CCRCs in Nonpreconstricted Tissues
The contraction response to 5-HT was quantified by CCRCs (0.01 to 60 mM) using Van Rossum's method. 24) The antagonistic potency of ketanserin was expressed as pK B (see data analysis), and the drug concentration used was 0.01 mM. After a control CCRC and 60 min washing under the conditions described above, antagonist was added to the bath solution 20 min before the end of the preceding equilibration period and another CCRC was constructed in the presence of the antagonist. Appropriate control CCRCs were carried out to check reproducibility (data not shown).
CCRCs in Preconstricted Tissues
Vasoconstrictor agents used were 1 mM prostaglandin F 2a (PGF 2a ) or 5 mM PE. When 0.3 mM ketanserin was added, the ring was incubated 20 min prior to the assay. The high concentration of PE (5 mM) was used because when 0.3 mM ketanserin was present it was necessary to increase the concentration of PE to obtain a measurable response (ketanserin pK B for a 1 receptors was 8.38Ϯ0.21, data not shown). In preconstricted tissues, the following were evaluated: a) 5-HT 2A -Independent Serotonin Response: Tissues were precontracted with 5 mM PE and allowed to stabilize. Cumulative concentrations of 5-HT or a-methyl-5-HT were added starting at 0.3 nM until a contraction was observed (Fig. 1A) . To retard this effect and better characterize the effect induced by low doses (nM) of 5-HT, 0.3 mM ketanserin was added during the assay to prevent interactions of the agonists with 5-HT 2A receptors 25) (Fig. 1B) . Antagonistic potencies of rauwolscine and cyproheptadine were expressed as pK B (see data analysis). For studies on different antagonists, experiments were done using one ring as the CCRC control and the other rings from the same animal were preincubated for 20 min with the antagonist (0.1 mM for rauwolscine and 0.01 mM for cyproheptadine). Neither of these antagonists had an effect on PE-induced contraction.
b) 5-HT 2A -Dependent Serotonin Response: After contraction with 5 mM PE tissues were allowed to stabilize and CCRCs to 5-HT were constructed, starting at 0.3 nM until the contraction reached a plateau (30 mM in the absence of ketanserin and 1 mM in the presence of 0.3 mM ketanserin). The pK B value of this antagonist was obtained in the same way as that described above for rauwolscine and cyproheptadine.
Responses to PE or PGF 2a were not well maintained in many preparations and this interfered with the measurement of agonist-induced relaxation. Preparations that did not maintain a reasonably stable contractile response to the vasoconstrictor agents or those exhibiting ill-defined relaxant responses to the agonists were discarded. For this reason, each preparation was always compared with another ring from the same animal contracted with the corresponding vasoconstrictor wich acted as a control. Because contractile responses were more stable with PE than with PGF 2a , studies of pharmacological characterization were done using PE as vasoconstrictor agent. Data Analysis 1. Potency of Aagonists: Potency was measured in terms of EC 50 (1/K A ). Agonist concentration-effect curves (for constriction and relaxation) were fitted to the following equation using the Kaleidagraph program (Synergy Software, Reading, PA, U.S.A.):
where E max , [A], and s represent the maximum response, agonist concentration, and curve slope, respectively. EC 50 is the concentration of agonist that produces 50% of the maximal response. E max was always considered to be 100% in both contraction and relaxation curves.
Values of EC 50 are given as meanϮS.E.M. For each calculated EC 50 , a minimum of 5 experiments (n) was carried out.
2. Potency of Antagonists: Calculation of apparent antagonist dissociation constants (K B ) was performed using the equation:
where B is the concentration of the antagonist used and dr represents the ratio (dose ratio) of concentrations (EC 50 ) that produced equivalent responses in the absence and presence of antagonist. 26, 27) Antagonistic potency of antagonists is expressed as pK B (Ϫlog K B ).
A minimum of 4 experiments (n) was carried out for each pK B determination.
In all cases the statistical significance of differences between two means (pϽ0.05) were estimated using Student's two-tailed t-test for unpaired data.
Drugs and Chemicals 5-HT hydrochloride, a-methyl-5-HT maleate, ketanserin tartrate, rauwolscine (a-yohimbine) hydrochloride, PGF 2a methyl ester, PE hydrochloride, and cyproheptadine hydrochloride were purchased from Sigma Biochemicals. All compounds, except for PGF 2a , were dissolved in distilled water. PGF 2a was dissolved in methanol at a stock concentration of 1 mM. Concentrations used for the assays were prepared daily in distilled water. None of the vehicles used had appreciable pharmacological effects.
RESULTS
When 5-HT was added cumulatively after preconstriction with either 1 mM PGF 2a or 5 mM PE in intact aorta, a typical concentration-dependent contractile response was observed between 0.3 mM and 60 mM (Fig. 1A) . However, when 5-HT was added after preconstriction with either 1 mM PGF 2a or 5 mM PE in the presence of 0.3 mM ketanserin (to block 5-
HT 2A receptor) a dual effect was observed (Fig. 1B) . This effect consisted of a very slight relaxation at concentrations of 0.3 nM to 3 mM and of a typical 5-HT 2A -mediated constriction from 30 mM to 1 mM. The contractile response was shifted to the right with respect to the control in the absence of ketanserin; in the presence of the antagonist the EC 50 in response to 5-HT was 260Ϯ4 mM while in the absence of the antagonist it was 4.65Ϯ0.60 mM.
Mechanical removal of endothelium abolished the relaxing effect in response to 5-HT ( Fig. 2A) , confirming the endothelium-dependent nature of the relaxant response. Comparison of the response to 5-HT in the absence and in the presence of endothelium is shown in Fig. 2 .
The EC 50 (nM) and slope of 5-HT for the relaxant effect were measured, and the values obtained were 43.10Ϯ4.00/ 0.72Ϯ0.14 and 32.02Ϯ4.12/0.92Ϯ0.10 with 5 mM PE and 1 mM PGF 2a as vasoconstrictor agents, respectively (Fig. 3) . Given the fact that the potency in inducing relaxation was independent of the vasoconstrictor agent used (pϾ0.05) and due to the greater instability of prostaglandin F 2a and the progressive loss of the ability to reproduce its contractile efficacy in additional runs, studies of pharmacological characterization of 5-HT receptors presented were performed using 5 mM PE as the vasoconstricive agent. The other agonist tested, a-methyl-5-HT, when added at concentrations of 0.3 nM to 3 mM to intact aorta in the presence of 0.3 mM ketanserin, evoked a slight relaxation similar to the one observed with 5-HT. The EC 50 was 57.11Ϯ8.50 nM Inset, example of a control contraction with 5 mm PE in the presence of 0.3 mm ketanserin in intact aorta. These experiments were repeated 7 and 10 times, respectively, obtaining similar results.
Fig. 2. Typical Recordings of CCRCs to 5-HT in Aorta in the Presence of 0.3 mM Ketanserin after Preconstriction with 5 mM PE (A) in EndotheliumDenuded Aorta and (B) in Intact Aorta
These experiments were repeated 7 and 13 times in denuded and intact aorta, respectively, obtaining similar results.
(data not shown), and it was also endothelium and preconstriction dependent.
Other types of antagonists, such as cyproheptadine and rauwolscine, caused parallel rightward displacements of relaxant CCRCs for 5-HT. pK B values were 8.92Ϯ0.12 and 7.15Ϯ0.12, respectively (Figs. 4A, B) . Table 1 summarizes potencies obtained for relaxant responses to the agonists (5-HT and a-methyl-5-HT) and apparent pK B for the antagonists (cyproheptadine and rauwolscine) tested. Potencies for the same ligands reported in the literature for 5-HT 1B and 5-HT 2B receptors, of which mRNAs were described in rat aorta, and that could mediate this endothelium-dependent 5-HT relaxant effect are also included and denoted as unknown receptor.
Concerning the 5-HT 2A receptor-mediated response, Fig. 5 show the parallel shift caused by ketanserin in CCRCs to 5-HT under the different conditions tested (absence/presence of endothelium and/or preconstriction). For CCRCs constructed in the basal tone, the pK B obtained for ketanserin was 8.93Ϯ 0.28 in the presence of endothelium (Fig. 5A ) and 8.67Ϯ0.16 in the absence of endothelium (Fig. 5B) . For CCRCs after preconstriction with PE, pK B obtained for the antagonist was 8.61Ϯ0.11 in the presence of endothelium (Fig. 5C ) and 8.31Ϯ0.10 in the absence of endothelium (Fig. 5D) . In no case were the differences statistically significant. Table 2 shows the results obtained for 5-HT (EC 50 ) and ketanserin (pK B ) under all the different conditions tested. In endothelium-denuded aorta and in the absence of preconstriction (typical conditions for 5-HT 2A study 1) ), the EC 50 for the agonist was 2.60Ϯ0.28 mM. In intact aorta without preconstriction it was higher (4.12Ϯ0.21 mM) and the differences were statistically significant (pϽ0.05). This was also observed in preconstricted tissues (pϽ0.05): EC 50 values for 5-HT were 2.22Ϯ0.40 and 4.65Ϯ0.60 mM in endothelium-denuded and in intact aorta, respectively.
DISCUSSION
In the present study, we described a dual effect of 5-HT in intact rat aorta: in addition to the classical 5-HT 2A -dependent contractile response, we found a very slight endotheliumand precontraction-dependent 5-HT mediated relaxation. We also have confirmed that the potency of 5-HT-induved contractions significantly diminished (pϽ0.05) in the presence of endothelium.
In rat isolated aorta the only functional receptor described is 5-HT 2A . 1) In view of this, it was unexpected to find that in rat aorta three of the four different 5-HT receptors (5-HT 2A , 5-HT 2B , 5-HT 1 B, 5-HT 7 ) described in the literature 2) are non functional. However, in vascular tissues it is well known that non functional receptors are sometimes expressed. 28, 29) Therefore, we used different experimental protocols to detect functional responses to 5-HT from endothelium and smooth muscle.
In intact rat isolated aorta preconstricted with either 1 mM PGF 2a or 5 mM PE, 5-HT has a potent constrictor effect at concentrations Ͼ0.1 mM. However, under the same conditions 5-HT has a dual effect in the presence of a high-affinity 5-HT 2A antagonist (ketanserin): a slight relaxant effect was observed at low concentrations (Ͻ1 mM) in addition to the already known constrictor effect.
The relaxant response detected was endothelium dependent, excluding the possible participation of the 5-HT 7 relaxant receptor of which mRNA was described in rat aorta, 2) given that this receptor was always described in smooth muscle (for a review see 12) ). The absence of a relaxant response for 5-HT 7 receptors could be due to the low mRNA density found for these receptors.
2) This relaxant effect was independent of the vasoconstrictor used (PE or PGF 2a ), because the potencies of 5-HT were not significantly different in the presence of both vasoconstrictor agents.
The small magnitude of this relaxant 5-HT-mediated response could explain the lack of significant relaxation reported by James et al. 30) Furthermore, Martin et al. 31) did not find any relaxant response to 5-HT when precontracting rat aorta with 10 mM PGF 2a in the presence of 3 mM ketanserin. In addition to the weakness of the relaxant response, this absence of relaxant response reported by other authors 31) could also be due to the different protocols used: higher concentrations of PGF 2a and ketanserin, interspecies differences between rats (Sprague-Dawley vs. Wistar rats), and the lack of a sufficiently sensitive system to study this effect which is within a narrow window of relaxation probably due to an unspecific release of endothelium-derived relaxing factor or nitric oxide (EDRF-NO) that follows constriction of the tissue. 30, 31) Atypical 5-HT receptors that mediate endothelium-dependent relaxation have been detected in numerous blood vessels. While some were initially classified as 5-HT 1 -like (a heterogeneous group that is currently subdivided into 5-HT 1B , 5-HT 1D , 5-HT 7 ) 32) (pig coronary arteries, 33) porcine vena cava 34) ), others may be tentatively classified as subtypes of the 5-HT 2 type (rabbit jugular vein, 35) rat jugular vein, 5, 25) porcine pulmonary arteries 3, 4, 36) ). Taking this into account as well as the presence of mRNA for 5-HT 2B and 5-HT 1B in rat aorta, 2) we have focused on the pharmacological characterization of these types of receptors. Table 1 summarizes the potencies of agonists and antagonists used in the study of 5-HT 1B and 5-HT 2B receptors as well as those obtained in our experiments on the relaxation responses to serotonergic agonists. The higher affinity of a-methyl-5-HT observed in our results seems to preclude the involvement of a 5-HT 1B receptor-mediated mechanism. Furthermore, the potencies of the two antagonists tested are in better agreement with those described for the 5-HT 2B receptor than for 5-HT 1B ; especially in the case of cyproheptadine. The pK B value obtained under our experimental conditions is similar to that reported for the 5-HT 2B receptor in rat stomach fundus. 37) In summary, our preliminary data suggest a pharmacological profile compatible with 5-HT 2B receptors, in low density and/or with low functional efficacy. However, further pharmacological characterization studies with 5-HT 2B -selective ligands should be carried out and the possible mechanism of action that mediates this relaxation determined. Although other authors have described a synergistic crosstalk between a 1 and 5-HT contractile receptors in rabbit ear artery 38) and in rabbit femoral artery, 39) in rat aorta we were not able to observe such potentiation. 5-HT potency for contractile responses remained constant in the presence and absence of preconstriction with PE (Table 2) or with PGF 2a and therefore, no silent receptors appeared in rat aorta under our experimental conditions. The factor that appears to affect 5-HT potency is the presence of endothelium: in CCRCs constructed in intact aorta, the EC 50 for 5-HT is significantly shifted to the right (pϽ0.05) in both curves constructed 588 Vol. 25, No. 5 40) 10.5Ϯ1.5 nM (K i ) 40) 7.01Ϯ0.10 (pA 2 ) 41) 9.14Ϯ0.25 (pA 2 ) 37) 5-HT 1B 67 nM (EC 50 ) 42) 1000 nM (K i ) 43) 6.0 (pK b ) 44) 6.1 (pK i ) 45) Fig under basal tone or after preconstriction. A possible "masking" influence of the 5-HT relaxant effect on the efficacy of the 5-HT 2A receptor was not determined. To study this phenomenon it would be necessary to construct two consecutive dual CCRCs to 5-HT in the absence and the presence of ketanserin to compare the E max of the first and second curves. The long duration of the first curve (about 100 min) made it impossible to measure 5-HT efficacy in a second CCRC reliably.
Ketanserin potency (measured as pK B ) for 5-HT 2A contractile receptor remained unaltered despite the presence of endothelium and/or preconstriction, as shown in Table 2 . Values of pK B for the antagonist were not significantly different under all conditions tested.
In conclusion, under our experimental conditions in rat aorta: i) There are only two functional 5-HT receptors, despite the four mRNAs described in the literature: a high- affinity endothelium-dependent relaxant receptor that mediates a weak response and of which the pharmacology could be compatible with an endothelial 5-HT 2B receptor, and 5-HT 2A contractile smooth muscle receptor. ii) No silent constrictor receptors were observed. iii) The contractile potency of 5-HT for 5-HT 2A receptor is significantly diminished by the presence of endothelium in both preconstricted and nonpreconstricted tissues.
